A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

Infection and immunity, 1996 - Am Soc Microbiol
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.

AI Fattom, J Sarwar, A Ortiz, R Naso - Infection and Immunity, 1996 - europepmc.org
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.

AI Fattom, J Sarwar, A Ortiz, R Naso - Infection and Immunity, 1996 - ncbi.nlm.nih.gov
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

AI Fattom, J Sarwar, A Ortiz… - Infection and …, 1996 - pubmed.ncbi.nlm.nih.gov
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

[PDF][PDF] A Staphylococcus aureus Capsular Polysaccharide (CP) Vaccine and CP-Specific Antibodies Protect Mice against Bacterial Challenge

ALII FATTOM, J SARWAR, A ORTIZ… - INFECTION AND …, 1996 - researchgate.net
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

AI Fattom, J Sarwar, A Ortiz, R Naso - Infection and Immunity, 1996 - cir.nii.ac.jp
抄録< jats: p> The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by
active immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP …

[PDF][PDF] A Staphylococcus aureus Capsular Polysaccharide (CP) Vaccine and CP-Specific Antibodies Protect Mice against Bacterial Challenge

ALII FATTOM, J SARWAR, A ORTIZ… - INFECTION AND …, 1996 - academia.edu
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

[PDF][PDF] A Staphylococcus aureus Capsular Polysaccharide (CP) Vaccine and CP-Specific Antibodies Protect Mice against Bacterial Challenge

ALII FATTOM, J SARWAR, A ORTIZ… - INFECTION AND …, 1996 - Citeseer
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

[引用][C] A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

AI FATTOM, J SARWAR, A ORTIZ… - Infection and …, 1996 - pascal-francis.inist.fr
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies
protect mice against bacterial challenge CNRS Inist Pascal-Francis CNRS Pascal and …

[引用][C] A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.

AI FOTTOM - Infect. Immun., 1996 - cir.nii.ac.jp
A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies
protect mice against bacterial challenge. | CiNii Research CiNii 国立情報学研究所 学術情報 …